BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10634803)

  • 21. Regulation of distinct steps of angiogenesis by different angiogenic molecules.
    Kumar R; Yoneda J; Bucana CD; Fidler IJ
    Int J Oncol; 1998 Apr; 12(4):749-57. PubMed ID: 9499433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
    Salcedo R; Wasserman K; Young HA; Grimm MC; Howard OM; Anver MR; Kleinman HK; Murphy WJ; Oppenheim JJ
    Am J Pathol; 1999 Apr; 154(4):1125-35. PubMed ID: 10233851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
    Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM
    Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Motility induced by human immunodeficiency virus-1 Tat on Kaposi's sarcoma cells requires platelet-activating factor synthesis.
    Biancone L; Cantaluppi V; Boccellino M; Bussolati B; Del Sorbo L; Conaldi PG; Albini A; Toniolo A; Camussi G
    Am J Pathol; 1999 Nov; 155(5):1731-9. PubMed ID: 10550329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
    Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
    Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The synthesis of platelet-activating factor modulates chemotaxis of monocytes induced by HIV-1 Tat.
    Del Sorbo L; DeMartino A; Biancone L; Bussolati B; Conaldi PG; Toniolo A; Camussi G
    Eur J Immunol; 1999 May; 29(5):1513-21. PubMed ID: 10359105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
    Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
    Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor and P-selectin.
    Montrucchio G; Lupia E; De Martino A; Silvestro L; Savu SR; Cacace G; De Filippi PG; Emanuelli G; Camussi G
    Circulation; 1996 Jun; 93(12):2152-60. PubMed ID: 8925584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Inoki I; Shiomi T; Hashimoto G; Enomoto H; Nakamura H; Makino K; Ikeda E; Takata S; Kobayashi K; Okada Y
    FASEB J; 2002 Feb; 16(2):219-21. PubMed ID: 11744618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1.
    Bernatchez PN; Rollin S; Soker S; Sirois MG
    J Cell Biochem; 2002; 85(3):629-39. PubMed ID: 11968003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization, quantification, and activation of platelet-activating factor receptor in human endometrium during the menstrual cycle: PAF stimulates NO, VEGF, and FAKpp125.
    Ahmed A; Dearn S; Shams M; Li XF; Sangha RK; Rola-Pleszczynski M; Jiang J
    FASEB J; 1998 Jul; 12(10):831-43. PubMed ID: 9657523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression.
    Nör JE; Christensen J; Mooney DJ; Polverini PJ
    Am J Pathol; 1999 Feb; 154(2):375-84. PubMed ID: 10027396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
    Wang H; Keiser JA
    Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
    Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
    Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of endothelial cell chemotaxis by sphingosine 1-phosphate and stabilization of endothelial monolayer barrier function by lysophosphatidic acid, potential mediators of hematopoietic angiogenesis.
    English D; Kovala AT; Welch Z; Harvey KA; Siddiqui RA; Brindley DN; Garcia JG
    J Hematother Stem Cell Res; 1999 Dec; 8(6):627-34. PubMed ID: 10645770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells.
    Wright TJ; Leach L; Shaw PE; Jones P
    Exp Cell Res; 2002 Nov; 280(2):159-68. PubMed ID: 12413882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small GTP-binding protein Rac is an essential mediator of vascular endothelial growth factor-induced endothelial fenestrations and vascular permeability.
    Eriksson A; Cao R; Roy J; Tritsaris K; Wahlestedt C; Dissing S; Thyberg J; Cao Y
    Circulation; 2003 Mar; 107(11):1532-8. PubMed ID: 12654612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis.
    Montrucchio G; Lupia E; Battaglia E; Passerini G; Bussolino F; Emanuelli G; Camussi G
    J Exp Med; 1994 Jul; 180(1):377-82. PubMed ID: 7516414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular smooth muscle cell growth-promoting factor/F-spondin inhibits angiogenesis via the blockade of integrin alphavbeta3 on vascular endothelial cells.
    Terai Y; Abe M; Miyamoto K; Koike M; Yamasaki M; Ueda M; Ueki M; Sato Y
    J Cell Physiol; 2001 Sep; 188(3):394-402. PubMed ID: 11473366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.